Cargando…

IRE1α Activation in Bone Marrow-Derived Dendritic Cells Modulates Innate Recognition of Melanoma Cells and Favors CD8(+) T Cell Priming

The IRE1α/XBP1s signaling pathway is an arm of the unfolded protein response (UPR) that safeguards the fidelity of the cellular proteome during endoplasmic reticulum (ER) stress, and that has also emerged as a key regulator of dendritic cell (DC) homeostasis. However, in the context of DC activation...

Descripción completa

Detalles Bibliográficos
Autores principales: Medel, Bernardita, Costoya, Cristobal, Fernandez, Dominique, Pereda, Cristian, Lladser, Alvaro, Sauma, Daniela, Pacheco, Rodrigo, Iwawaki, Takao, Salazar-Onfray, Flavio, Osorio, Fabiola
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6338037/
https://www.ncbi.nlm.nih.gov/pubmed/30687308
http://dx.doi.org/10.3389/fimmu.2018.03050
_version_ 1783388389574180864
author Medel, Bernardita
Costoya, Cristobal
Fernandez, Dominique
Pereda, Cristian
Lladser, Alvaro
Sauma, Daniela
Pacheco, Rodrigo
Iwawaki, Takao
Salazar-Onfray, Flavio
Osorio, Fabiola
author_facet Medel, Bernardita
Costoya, Cristobal
Fernandez, Dominique
Pereda, Cristian
Lladser, Alvaro
Sauma, Daniela
Pacheco, Rodrigo
Iwawaki, Takao
Salazar-Onfray, Flavio
Osorio, Fabiola
author_sort Medel, Bernardita
collection PubMed
description The IRE1α/XBP1s signaling pathway is an arm of the unfolded protein response (UPR) that safeguards the fidelity of the cellular proteome during endoplasmic reticulum (ER) stress, and that has also emerged as a key regulator of dendritic cell (DC) homeostasis. However, in the context of DC activation, the regulation of the IRE1α/XBP1s axis is not fully understood. In this work, we report that cell lysates generated from melanoma cell lines markedly induce XBP1s and certain members of the UPR such as the chaperone BiP in bone marrow derived DCs (BMDCs). Activation of IRE1α endonuclease upon innate recognition of melanoma cell lysates was required for amplification of proinflammatory cytokine production and was necessary for efficient cross-presentation of melanoma-associated antigens without modulating the MHC-II antigen presentation machinery. Altogether, this work provides evidence indicating that ex-vivo activation of the IRE1α/XBP1 pathway in BMDCs enhances CD8(+) T cell specific responses against tumor antigens.
format Online
Article
Text
id pubmed-6338037
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-63380372019-01-25 IRE1α Activation in Bone Marrow-Derived Dendritic Cells Modulates Innate Recognition of Melanoma Cells and Favors CD8(+) T Cell Priming Medel, Bernardita Costoya, Cristobal Fernandez, Dominique Pereda, Cristian Lladser, Alvaro Sauma, Daniela Pacheco, Rodrigo Iwawaki, Takao Salazar-Onfray, Flavio Osorio, Fabiola Front Immunol Immunology The IRE1α/XBP1s signaling pathway is an arm of the unfolded protein response (UPR) that safeguards the fidelity of the cellular proteome during endoplasmic reticulum (ER) stress, and that has also emerged as a key regulator of dendritic cell (DC) homeostasis. However, in the context of DC activation, the regulation of the IRE1α/XBP1s axis is not fully understood. In this work, we report that cell lysates generated from melanoma cell lines markedly induce XBP1s and certain members of the UPR such as the chaperone BiP in bone marrow derived DCs (BMDCs). Activation of IRE1α endonuclease upon innate recognition of melanoma cell lysates was required for amplification of proinflammatory cytokine production and was necessary for efficient cross-presentation of melanoma-associated antigens without modulating the MHC-II antigen presentation machinery. Altogether, this work provides evidence indicating that ex-vivo activation of the IRE1α/XBP1 pathway in BMDCs enhances CD8(+) T cell specific responses against tumor antigens. Frontiers Media S.A. 2019-01-04 /pmc/articles/PMC6338037/ /pubmed/30687308 http://dx.doi.org/10.3389/fimmu.2018.03050 Text en Copyright © 2019 Medel, Costoya, Fernandez, Pereda, Lladser, Sauma, Pacheco, Iwawaki, Salazar-Onfray and Osorio. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Immunology
Medel, Bernardita
Costoya, Cristobal
Fernandez, Dominique
Pereda, Cristian
Lladser, Alvaro
Sauma, Daniela
Pacheco, Rodrigo
Iwawaki, Takao
Salazar-Onfray, Flavio
Osorio, Fabiola
IRE1α Activation in Bone Marrow-Derived Dendritic Cells Modulates Innate Recognition of Melanoma Cells and Favors CD8(+) T Cell Priming
title IRE1α Activation in Bone Marrow-Derived Dendritic Cells Modulates Innate Recognition of Melanoma Cells and Favors CD8(+) T Cell Priming
title_full IRE1α Activation in Bone Marrow-Derived Dendritic Cells Modulates Innate Recognition of Melanoma Cells and Favors CD8(+) T Cell Priming
title_fullStr IRE1α Activation in Bone Marrow-Derived Dendritic Cells Modulates Innate Recognition of Melanoma Cells and Favors CD8(+) T Cell Priming
title_full_unstemmed IRE1α Activation in Bone Marrow-Derived Dendritic Cells Modulates Innate Recognition of Melanoma Cells and Favors CD8(+) T Cell Priming
title_short IRE1α Activation in Bone Marrow-Derived Dendritic Cells Modulates Innate Recognition of Melanoma Cells and Favors CD8(+) T Cell Priming
title_sort ire1α activation in bone marrow-derived dendritic cells modulates innate recognition of melanoma cells and favors cd8(+) t cell priming
topic Immunology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6338037/
https://www.ncbi.nlm.nih.gov/pubmed/30687308
http://dx.doi.org/10.3389/fimmu.2018.03050
work_keys_str_mv AT medelbernardita ire1aactivationinbonemarrowderiveddendriticcellsmodulatesinnaterecognitionofmelanomacellsandfavorscd8tcellpriming
AT costoyacristobal ire1aactivationinbonemarrowderiveddendriticcellsmodulatesinnaterecognitionofmelanomacellsandfavorscd8tcellpriming
AT fernandezdominique ire1aactivationinbonemarrowderiveddendriticcellsmodulatesinnaterecognitionofmelanomacellsandfavorscd8tcellpriming
AT peredacristian ire1aactivationinbonemarrowderiveddendriticcellsmodulatesinnaterecognitionofmelanomacellsandfavorscd8tcellpriming
AT lladseralvaro ire1aactivationinbonemarrowderiveddendriticcellsmodulatesinnaterecognitionofmelanomacellsandfavorscd8tcellpriming
AT saumadaniela ire1aactivationinbonemarrowderiveddendriticcellsmodulatesinnaterecognitionofmelanomacellsandfavorscd8tcellpriming
AT pachecorodrigo ire1aactivationinbonemarrowderiveddendriticcellsmodulatesinnaterecognitionofmelanomacellsandfavorscd8tcellpriming
AT iwawakitakao ire1aactivationinbonemarrowderiveddendriticcellsmodulatesinnaterecognitionofmelanomacellsandfavorscd8tcellpriming
AT salazaronfrayflavio ire1aactivationinbonemarrowderiveddendriticcellsmodulatesinnaterecognitionofmelanomacellsandfavorscd8tcellpriming
AT osoriofabiola ire1aactivationinbonemarrowderiveddendriticcellsmodulatesinnaterecognitionofmelanomacellsandfavorscd8tcellpriming